These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 10698117)

  • 1. Effects of neonatal treatment with Tyr-MIF-1 and naloxone on the long-term body weight gain induced by repeated postnatal stressful stimuli.
    d'Amore A; Loizzo A
    Peptides; 1999 Dec; 20(12):1425-30. PubMed ID: 10698117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrathecal Tyr-W-MIF-1 produces potent, naloxone-reversible analgesia modulated by alpha 2-adrenoceptors.
    Gergen KA; Zadina JE; Kastin AJ; Paul D
    Eur J Pharmacol; 1996 Mar; 298(3):235-9. PubMed ID: 8846821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tyr-MIF-1 attenuates antinociceptive responses induced by three models of stress-analgesia.
    Galina ZH; Kastin AJ
    Br J Pharmacol; 1987 Apr; 90(4):669-74. PubMed ID: 2884005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MIF-1 and Tyr-MIF-1 antagonize morphine and opioid but not non-opioid stress-induced analgesia in the snail, Cepaea nemoralis.
    Kavaliers M
    Peptides; 1987; 8(1):1-5. PubMed ID: 2883631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analgesic effects of Tyr-W-MIF-1: a mixed mu2-opioid receptor agonist/mu1-opioid receptor antagonist.
    Gergen KA; Zadina JE; Paul D
    Eur J Pharmacol; 1996 Nov; 316(1):33-8. PubMed ID: 8982647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of Tyr-MIF-1, MIF-1, and naloxone on peptide YY-induced hyperphagia.
    Hagan MM; Moss DE
    Peptides; 1994; 15(2):243-5. PubMed ID: 7911993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential inhibitory effects of MIF-1, Tyr-MIF-1, naloxone and beta-funaltrexamine on body rotation-induced analgesia in the meadow vole, Microtus pennsylvanicus.
    Lipa SM; Kavaliers M; Ossenkopp KP
    Peptides; 1989; 10(3):493-7. PubMed ID: 2571138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Tyr-W-MIF-1 analog containing D-Pro2 acts as a selective mu2-opioid receptor antagonist in the mouse.
    Watanabe H; Nakayama D; Ito K; Watanabe C; Mizoguchi H; Fujimura T; Murayama K; Kawamura S; Sato T; Sakurada C; Sakurada T; Sakurada S
    J Pharmacol Exp Ther; 2005 Mar; 312(3):1075-81. PubMed ID: 15561796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Tyr-W-MIF-1 analog containing D-Pro2 discriminates among antinociception in mice mediated by different classes of mu-opioid receptors.
    Nakayama D; Watanabe C; Watanabe H; Mizoguchi H; Sakurada T; Sakurada S
    Eur J Pharmacol; 2007 Jun; 563(1-3):109-16. PubMed ID: 17343845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral administration of Tyr-MIF-1 stimulates gastric emptying and gastrointestinal motility in rodents.
    Million M; Fioramonti J; Bueno L
    Peptides; 1992; 13(3):469-74. PubMed ID: 1355905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex differences in naloxone- and Tyr-MIF-1-induced hypoalgesia.
    Kavaliers M; Innes DG
    Peptides; 1993; 14(5):1001-4. PubMed ID: 7904339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tyr-MIF-1 acts as an opiate antagonist in the tail-flick test.
    Kastin AJ; Stephens E; Ehrensing RH; Fischman AJ
    Pharmacol Biochem Behav; 1984 Dec; 21(6):937-41. PubMed ID: 6151669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of Tyr-MIF-1 and naloxone in two animal models involving benzodiazepine.
    Kastin AJ; Schwartzenburg D; Tsui L; Miller LG; Olson GA; Olson RD
    Brain Res Bull; 1989 Dec; 23(6):443-6. PubMed ID: 2575442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study on the antinociceptive action of Tyr-K-MIF-1, a peptide from the MIF family.
    Zamfirova R; Bocheva A; Dobrinova Y; Todorov S
    Auton Autacoid Pharmacol; 2007 Apr; 27(2):93-8. PubMed ID: 17391278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolerance and morphine-induced cross-tolerance are not shown to Tyr-W-MIF-1 analgesia.
    Bell RL; Vaccarino AL; Olson RD; Olson GA; Nores WL; Cambre JG; Zadina JE; Kastin AJ
    Peptides; 1999; 20(8):971-8. PubMed ID: 10503776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory influences of MIF-1 (PLG) and Tyr-MIF-1 (YPLG) on aggression and defeat-induced analgesia in mice.
    Kavaliers M; Hirst M
    Peptides; 1986; 7(6):1007-10. PubMed ID: 2882493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Existence of antiopiate systems as illustrated by MIF-1/Tyr-MIF-1.
    Galina ZH; Kastin AJ
    Life Sci; 1986 Dec; 39(23):2153-9. PubMed ID: 2878336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tyr-MIF-1 and hemorphin can act as opiate agonists as well as antagonists in the guinea pig ileum.
    Zadina JE; Kastin AJ; Kersh D; Wyatt A
    Life Sci; 1992; 51(11):869-85. PubMed ID: 1355851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effects of prolyl-leucyl-glycinamide and naloxone on morphine-induced inhibition of gastrointestinal transit.
    Pillai NP; Bhargava HN
    Pharmacol Biochem Behav; 1984 Sep; 21(3):365-8. PubMed ID: 6149566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiopioid properties of the TYR-MIF-1 family.
    Bocheva A; Dzambazova-Maximova E
    Methods Find Exp Clin Pharmacol; 2004 Nov; 26(9):673-7. PubMed ID: 15632952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.